Effects of Kampo medicines on the prevention of COVID-19

Effects of Kampo medicines on the prevention of COVID-19 - Prevention of COVID-19 with Kampo medicines

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048389

Enrollment

200

Registered

2023-12-24

Start date

2021-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease 2019

Interventions

Someone which has Kampo medicines (5days, 7.5g/day) Someone which has no Kampo medicines

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Someone which want to have Kampo medicines after exposure to COVID-19 for prevention

Exclusion criteria

Exclusion criteria: Someone which has a history of side effects to Kampo medicines

Design outcomes

Primary

Measure	Time frame
onset after exposure to infection	—

Secondary

Measure	Time frame
Worsening after onset of infection	—

Countries

Japan

Contacts

Public ContactSatoru Chiba

Sapporo Suzuki Hospital Department of Internal Medicine

chibas_0317@yahoo.co.jp0117095511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026